Targeting Pyroptosis: New Insights into the Treatment of Diabetic Microvascular Complications

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• Pyroptosis is a pro-inflammatory programmed cell death pathway.
• It involves inflammatory caspases, gasdermin D (GSDMD) cleavage, and cytokine release (IL-1β, IL-18).
• Hyperglycemia-induced cellular stress is a known trigger for pyroptosis.

Purpose of the Study:

• To review and discuss the molecular mechanisms of pyroptosis in diabetic microvascular complications.
• To explore the regulation and cellular effects of pyroptosis in conditions like diabetic nephropathy, retinopathy, and cardiomyopathy.
• To offer insights for developing improved therapeutic interventions for these complications.

Main Methods:

• Literature review of recent studies on pyroptosis and diabetic microvascular complications.
• Synthesis of information on molecular pathways, regulatory mechanisms, and cellular impacts.
• Analysis of the role of pyroptosis in diabetic nephropathy, retinopathy, and cardiomyopathy.

Main Results:

• Pyroptosis is implicated in the pathogenesis of diabetic microvascular complications.
• Various signaling pathways regulate pyroptosis under hyperglycemic conditions.
• Cellular stress due to hyperglycemia activates pyroptosis, contributing to tissue damage.

Conclusions:

• Pyroptosis plays a significant role in the development and progression of diabetic microvascular complications.
• Targeting pyroptosis pathways presents a potential therapeutic avenue for managing diabetic complications.
• Further research is needed to fully elucidate the therapeutic potential of modulating pyroptosis.